Skip to content
Screener

Puma Biotechnology PBYI Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$56.5MBeat by $3.5M
EPS$0.19Beat by $0.15
Revenue estimate$53.0M
EPS estimate$0.04

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$57.5M
EPS estimate$0.11

FAQ

When did Puma Biotechnology report Q2 2026 earnings?
Puma Biotechnology (PBYI) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Puma Biotechnology's Q2 2026 revenue and EPS?
Puma Biotechnology reported revenue of $56.5M and eps of $0.19 for Q2 2026.
Did Puma Biotechnology beat estimates in Q2 2026?
Revenue beat the consensus estimate of $53.0M by $3.5M. EPS beat the consensus estimate of $0.04 by $0.15.
How did Puma Biotechnology's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.8% from $52.4M a year earlier and eps grew 26.7% from $0.15.
Where can I find Puma Biotechnology's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-026282) and the 10-Q periodic report (0001437749-26-026311) directly on SEC EDGAR. The filing index links above go to sec.gov.